Out of stock

This item is currently unavailable

Translational Research in Breast Cancer: Biomarker Diagnosis and Therapies

Out of stock

Price data checked 7 days ago

View at Amazon

One email. No newsletter. No nudges.

Out of stock for 7 days. The last 3 returns each lasted under a day — get on the list.

Out of stock 7 days · usually back within 14 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
25 August 2025
Listed Since
10 July 2025

Barcode

No barcode data available

Similar Products You Might Like

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
97% match

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products

Out of stock 16 Jun 2026
The 2025-2030 World Outlook for Breast Cancer Screenings
97% match

The 2025-2030 World Outlook for Breast Cancer Screenings

Out of stock 18 Jun 2026
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
97% match

The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments

Out of stock 27 Jun 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
96% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 11 Jul 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
96% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 18 Apr 2026
Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches
96% match

Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches

Springer

£106.47 11 Jul 2026
Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches
96% match

Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches

Springer

£128.26 16 Apr 2026
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
96% match

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Out of stock 11 Jun 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
96% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 11 Jul 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
96% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£217.93 09 Jul 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
96% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 14 Apr 2026
Breast Cancer: Carcinogenesis, Cell Growth and Signalling Pathways
96% match

Breast Cancer: Carcinogenesis, Cell Growth and Signalling Pathways

IntechOpen

£158.35 06 Jul 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
96% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 15 Apr 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
96% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 13 Jun 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
96% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 17 Apr 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
96% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 17 Jun 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 18 Jun 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
96% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India

£515.00 17 Jun 2026
Diagnosis and Management of Breast Tumors: A Practical Handbook and Multidisciplinary Approach
96% match

Diagnosis and Management of Breast Tumors: A Practical Handbook and Multidisciplinary Approach

Springer

£80.64 12 Jun 2026
Current Trends in Breast Cancer Pathology, Screening, Diagnosis and Treatments
96% match

Current Trends in Breast Cancer Pathology, Screening, Diagnosis and Treatments

Academic Press

£118.96 16 Apr 2026
Screening and Risk Reduction Strategies for Breast Cancer: Imaging Modality and Risk-Reduction Approaches
96% match

Screening and Risk Reduction Strategies for Breast Cancer: Imaging Modality and Risk-Reduction Approaches

Springer

£101.15 20 Apr 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
96% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 13 Jun 2026
Breast Cancer: From Biology to Medicine
96% match

Breast Cancer: From Biology to Medicine

IntechOpen

£147.51 19 Apr 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
96% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 13 Jun 2026